Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

SHA:603127 Revenue

Joinn Laboratories(China)Co.,Ltd. had revenue of 484.09M CNY in the quarter ending September 30, 2026, with 53.01% growth. This brings the company's total for the last twelve months to 1.86B, up 11.54% year-over-year. In the year 2025, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 1.66B, down -17.87%. That makes Joinn Laboratories(China)Co.,Ltd. the 15,029th largest company in the world by revenue and 2,703rd in China.

• Revenue (ttm): 1.86B
• Revenue Growth: +11.54%
• P/S Ratio: 16.29
• Revenue / Employee: 744.23K
• Employees: 2,500
• Market Cap: 29.38B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Non-Clinical Drug Research Services 1.58B 77.5%
• Supply of Experimental Models 384.29M 18.9%
• Clinical Services and Others 72.83M 3.6%

By Geography

Chart

• China 1.20B 72.7%
• Overseas 453.29M 27.3%

Fiscal year ended Dec 31, 2025 See the full SHA:603127 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.66B	-360.71M	-17.87%
Dec 31, 2024	2.02B	-358.15M	-15.07%
Dec 31, 2023	2.38B	108.52M	4.78%
Dec 31, 2022	2.27B	751.29M	49.54%
Dec 31, 2021	1.52B	440.78M	40.97%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error